XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2

Organization and Description of Business	6 Months Ended
	Jun. 30, 2020
Organization and Basis of Presentation [Abstract]
ORGANIZATION AND DESCRIPTION OF BUSINESS	NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS INmune Bio, Inc. (the "Company" or "INmune Bio") was organized in the State of Nevada on September 25, 2015, and is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where the innate immune system is not functioning normally and contributing to the patient's disease. INmune Bio's focus is on the innate immune system that include natural killer cells ("NK cells"), hepatic stellate cells of the liver (HSC cells), myeloid derived suppressor cells ("MDSC cells"), microglial cells and dendritic cells ("DC cells"), to offer unique therapeutic opportunities. INmune Bio plans to develop their four existing drug platforms: INKmune ("INKmune") which primes NK cells, INB03 ("INB03") which down regulates MDSC cells, LivNate, which targets soluble TNF – a key cytokine driving pathologic chronic inflammation, and XPro1595 that targets microglial cell activation in the brain – a cause of neuroinflammation.  INmune Bio is also initiating a clinical program to determine if the Company's TNF Inhibitor ("DN-TNF") platform may prevent complications of cytokine storm from COVID-19. The Company has been actively monitoring the novel coronavirus ("COVID-19") situation and its impact globally. The Company has continued to operate as it had prior to the COVID-19 pandemic with minimal change, other than for enhanced safety measures intended to prevent the spread of the virus.

X

- References

No definition available.

+ Details

Name:	inmb_OrganizationAndBasisOfPresentationAbstract
Namespace Prefix:	inmb_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-URI http://asc.fasb.org/topic&trid=2122149

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479

+ Details

Name:	us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration